Drugs / Tongmai Jiangtang Capsule
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06908473 | Apr 2025 → Jul 2028 expected | cerebrovascular disorder, metabolic syndrome X | Guangdong Provincial Hospital of Traditional Chinese Medicine | Enrolling by invitation | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tongmai Jiangtang Capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06908473 ↗ |
| Known as | TJC | “The study employs Tongmai Jiangtang Capsule (TJC), a traditional Chinese medicine compound formulated based on TCM theory.” NCT06908473 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “a traditional Chinese medicine compound formulated based on TCM theory” NCT06908473 ↗ |
| Route | Oral | “taken orally” NCT06908473 ↗ |